Alternatives to ANI Pharmaceuticals

AI-powered platform for designing novel molecular structures for new medicines.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered platform accelerating biological research and drug discovery.